Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-09

Clinical Trial Update: Pharmacogenetics of Antidepressant-Induced Disinhibition

View source ↗

Summary

A recruitment study investigating how pharmacogenetics influence antidepressant-induced disinhibition. It targets obsessive-compulsive disorder, anxiety disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Calgary | Conditions: Obsessive-Compulsive Disorder, Anxiety Disorders | Status: RECRUITING